secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001420720-24-000049
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio updates corporate presentation; no specific material changes disclosed
---------------------------------------------------------------------------

- iBio furnished an updated corporate presentation dated October 2024, focused on precision antibody therapeutics powered by machine learning.
- No new financial guidance, pipeline milestones, or operational metrics were provided in the 8-K filing.
- The presentation is furnished under Regulation FD and not incorporated by reference into SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000049/0001420720-24-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000049/ibio-20241023x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-24-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer